Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05555147
Other study ID # TJ2012S152
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date September 28, 2023

Study information

Verified date September 2022
Source Tongji Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The endoscopic binostril transnasal transsphenoidal resection of pituitary procedures often cause intense pain which is difficult to suppress at the depth of conventional general anesthesia, resulting in severe hemodynamic fluctuations in patients. Infraorbital and infratrochlear nerve block can block the pain signal caused by the endoscopic binostril transnasal transsphenoidal resection of pituitary theoretically, which has been proven to provide satisfactory analgesia after septorhinoplasty. However, whether bilateral infraorbital and infratrochlear nerve block can provide stable hemodynamics and reduce the hemodynamic fluctuation the patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary remains unclear.


Description:

Surgical stimulation is one of the important factors leading to hemodynamic fluctuation and affecting postoperative recovery quality. The endoscopic binostril transnasal transsphenoidal resection of pituitary procedures often cause intense pain because of there were numerous nerve endings at the surgical site which is originated from branches of the trigeminal nerve (including infraorbital and infratrochlear nerve). It's difficult to suppress intraoperative stimulation at the depth of conventional general anesthesia, resulting in severe hemodynamic fluctuations in patients. It's reported that pterygomaxillary fossa block can inhibit hypertension caused by surgical procedures, however the block may cause complications because of its complicated operations. Infraorbital and infratrochlear nerve block can block the pain signal caused by the endoscopic binostril transnasal transsphenoidal resection of pituitary theoretically, which has been proven to provide satisfactory analgesia after septorhinoplasty. However, whether bilateral infraorbital and infratrochlear nerve block can reduce the pain in the patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary remains unclear. Therefore, the investigators propose the hypothesis that preoperative bilateral infraorbital and infratrochlear nerve block could effectively reduce the pain in patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary. The objective of this study is to observe the heart rate and blood pressure at a specific point in time during the operation and pain at 2, 8, 24, 48 hours postoperatively between adult patients receiving or not receiving bilateral infraorbital and infratrochlear nerve block.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 120
Est. completion date September 28, 2023
Est. primary completion date September 28, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - 1. Elective endoscopic binostril transnasal transsphenoidal resection - 2. Patients aged between 18 and 65. - 3. American Society of Anesthesiologists (ASA) physical status I, ? and III Exclusion Criteria: - 1. Emergency operation. - 2. Patients allergic to ropivacaine. - 3. Infection nearby the puncture point. - 4. Patients with preoperative usage of sedative and analgesic drugs with history of alcohol abuse. - 5. Patient with renal insufficiency or hepatic failure. - 6. Patients who have undergone craniotomy in the recent 6 months. - 7. Pregnant or lactating women, being participating in other studies. - 8. Patients unable to cooperate.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
nerve block with 0.5% ropivacaine
After general anesthesia, the patients will receive bilateral infraorbital and infratrochlear nerve block 30 minutes prior to surgery. Infraorbital nerve block is performed while using an extraoral approach. A 25-gauge needle was inserted laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. The index finger of the non-dominant hand was positioned above the infraorbital foramen, and the needle was advanced until it was felt beneath the finger. 2 ml of the 0.5% ropivacaine slowly injected after negative aspiration of blood was confirmed. Inserting the needle 1 cm above the inner canthus, targeting the junction of the orbit and the nasal bone, performed infratrochlear nerve block. After negative aspiration of blood, 1 ml of the 0.5% ropivacaine was injected. Contralateral nerve block was performed in the same manner.
Other:
without any nerve block
Patients receiving general anesthesia without Infraorbital and Infratrochlear nerve block.

Locations

Country Name City State
China Tongji Hospital Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Tongji Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other incidence of postoperative nausea and vomiting (PONV) within 24 hours within 24 hours after surgery, the investigators record the number of patients who suffer from PONV, and then calculate the incidence as: the number of patient suffering from PONV/the total number in corresponding group within 24h after surgery
Other incidence of postoperative nausea and vomiting (PONV) within 48 hours within 48 hours after surgery, the investigators record the number of patients who suffer from PONV, and then calculate the incidence as: the number of patient suffering from PONV/the total number in corresponding group within 48 hours after surgery
Other Ramsay sedation scale (RSS) when patient enters PACU (immediately after surgery) Ramsay sedation scale (RSS) when patient enters PACU (immediately after surgery). The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). when patient enters PACU (immediately after surgery)
Other Ramsay sedation scale (RSS) before patient leaves PACU Ramsay sedation scale (RSS) before patient leaves PACU. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). before patient leaves PACU
Other Ramsay sedation scale (RSS) 2 hours after surgery Ramsay sedation scale (RSS) 2 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). 2 hours after surgery
Other Ramsay sedation scale (RSS) 8 hours after surgery Ramsay sedation scale (RSS) 8 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). 8 hours after surgery
Other Ramsay sedation scale (RSS) 24 hours after surgery Ramsay sedation scale (RSS) 24 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). 24 hours after surgery
Other Ramsay sedation scale (RSS) 48 hours after surgery Ramsay sedation scale (RSS) 48 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation). 48 hours after surgery
Other operation time from the time of surgery beginning until end time of surgery from the time of surgery beginning until end time of surgery
Other anesthesia time from the time of anesthesia beginning until end time of anesthesia from the time of anesthesia beginning until end time of anesthesia
Other awakening time from the time of anesthesia end until the time of patient awaken from the time of anesthesia end until the time of patient awaken
Other PACU staying time time from the time of patient coming in PACU until the time of patient coming out PACU from the time of patient coming in PACU until the time of patient coming out PACU
Other anesthetic dosage use dosage of anesthetic drug during operation during surgery
Other urine volume urine volume during surgery during surgery
Other bleeding volume bleeding volume during surgery during surgery
Other maintenance infusion rate of remifentanil infusion rate of remifentanil for maintaining effective analgesic effect during surgery during surgery
Other the dosage of remedial painkillers (remifentanil) the dosage of remedial painkillers (remifentanil) during surgery during surgery
Other the dosage of remedial perdipine the dosage of remedial perdipine during surgery during surgery
Other the dosage of remedial esmolol the dosage of remedial esmolol during surgery during surgery
Other the time of initial administration of remedial antiemetics within 48 hours the time of initial administration of remedial antiemetics within 48 hours after surgery within 48 hours after surgery
Other the dosage of remedial antiemetics within 48 hours the dosage of remedial antiemetics within 48 hours after surgery within 48 hours after surgery
Other incidence of hematoma at the block point in both two groups within 24 hours within 24 hours after operation, the investigators record the number of patients who suffer from hematoma at the block point, and then calculate the incidence as: the number of patient suffering from hematoma at the block point/the total number in corresponding group within 24 hours after surgery
Other incidence of infection at the block point in both two groups within 24 hours within 24 hours after operation, the investigators record the number of patients who suffer from infection at the block point, and then calculate the incidence as: the number of patient suffering from infection at the block point/the total number in corresponding group within 24 hours after surgery
Other incidence of local anesthetic toxicity in both two groups within 24 hours within 24 hours after operation, the investigators record the number of patients who suffer from local anesthetic toxicity, and then calculate the incidence as: the number of patient suffering from local anesthetic toxicity/the total number in corresponding group within 24 hours after surgery
Primary mean arterial pressure (MAP) before nerve block mean arterial pressure (MAP) before nerve block before nerve block
Primary heat rate (HR) before nerve block heat rate (HR) before nerve block before nerve block
Primary MAP within 10 minutes after nerve block MAP within 10 minutes after nerve block within 10 minutes after nerve block
Primary HR within 10 minutes after nerve block HR within 10 minutes after nerve block within 10 minutes after nerve block
Primary MAP before nasal mucosal dissection MAP before nasal mucosal dissection before nasal mucosal dissection
Primary HR before nasal mucosal dissection HR before nasal mucosal dissection before nasal mucosal dissection
Primary MAP immediately after nasal mucosal dissection MAP immediately after nasal mucosal dissection immediately after nasal mucosal dissection
Primary HR immediately after nasal mucosal dissection HR immediately after nasal mucosal dissection immediately after nasal mucosal dissection
Primary MAP before septum resection MAP before septum resection before septum resection
Primary HR before septum resection HR before septum resection before septum resection
Primary MAP immediately after septum resection MAP immediately after septum resection immediately after septum resection
Primary HR immediately after septum resection HR immediately after septum resection immediately after septum resection
Primary MAP before sella bone resection MAP before sella bone resection before sella bone resection
Primary HR before sella bone resection HR before sella bone resection before sella bone resection
Primary MAP after sella bone resection MAP after sella bone resection before sella bone resection
Primary HR immediately after sella bone resection HR immediately after sella bone resection immediately after sella bone resection
Primary MAP before dural incision of sella MAP before dural incision of sella before dural incision of sella
Primary HR before dural incision of sella HR before dural incision of sella before dural incision of sella
Primary MAP immediately after dural incision of sella MAP immediately after dural incision of sella immediately after dural incision of sella
Primary HR immediately after dural incision of sella HR immediately after dural incision of sella immediately after dural incision of sella
Primary MAP before exploration of pituitary fossa MAP before exploration of pituitary fossa before exploration of pituitary fossa
Primary HR before exploration of pituitary fossa HR before exploration of pituitary fossa before exploration of pituitary fossa
Primary MAP immediately after exploration of pituitary fossa MAP immediately after exploration of pituitary fossa immediately after exploration of pituitary fossa
Primary HR immediately after exploration of pituitary fossa HR immediately after exploration of pituitary fossa immediately after exploration of pituitary fossa
Secondary numerical rating scale (NRS) score when patient enters post-anaesthesia care unit (PACU) (immediately after surgery) numerical rating scale (NRS) score when patient enters PACU (immediately after surgery). The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. when patient enters PACU (immediately after surgery)
Secondary numerical rating scale (NRS) score before patient leaves PACU numerical rating scale (NRS) score before patient leaves PACU. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. before patient leaves PACU
Secondary NRS 2 hours after surgery NRS 2 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. 2 hours after surgery
Secondary NRS 8 hours after surgery NRS 8 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. 8 hours after surgery
Secondary NRS 24 hours after surgery NRS 24 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. 24 hours after surgery
Secondary NRS 48 hours after surgery NRS 48 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method. 48 hours after surgery
Secondary quality of recovery Scale: Quality of Recovery-15 (QoR-15) 1 day after surgery quality of recovery Scale (QoR-15): QoR-15 1 day after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality. 1 day after surgery
Secondary quality of recovery Scale: QoR-15 3 days after surgery quality of recovery Scale: QoR-15 3 days after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality. 3 days after surgery
Secondary quality of recovery Scale: QoR-15 7 days after surgery quality of recovery Scale: QoR-15 7 days after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality. 7 days after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Recruiting NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care